Heme: A versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases

Cell Research

Volumn 16, Issue 8, 2006, Pages 681-692

  Mense, Sarah M ^a   Zhang, Li ^a  

^a Mailman School of Public Health ^*  (United States)

Author keywords

Bach1; Hap1; Heme signaling; HRI; IRR; Oxygen sensing

Indexed keywords

BACH1 PROTEIN, HUMAN; BACTERIAL PROTEIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; FANCONI ANEMIA PROTEIN; FUNGAL PROTEIN; HAP1 PROTEIN, S CEREVISIAE; HEME; HEME OXYGENASE 1; IRON; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; RAS PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; BRADYRHIZOBIUM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIAL PROTEINS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BRADYRHIZOBIUM; DNA-BINDING PROTEINS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION; HEME; HEME OXYGENASE-1; HUMANS; IRON; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATION-REDUCTION; OXYGEN; RAS PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

BACTERIA (MICROORGANISMS); BRADYRHIZOBIUM JAPONICUM; EUKARYOTA; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 33747453769     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7310086     Document Type: Review

References (170)

1. Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudt AL, Sly WS, et al, eds. The metabolic and molecular bases of inherited disease. New York: The McGraw-Hill Companies Inc., 2001:2991-3062.
2. O'Brian MR, Thony-Meyer L. Biochemistry, regulation and genomics of haem biosynthesis in prokaryotes. Adv Microb Physiol 2002; 46:257-318.
3. Labbe-Bois R, Labbe P. Tetrapyrrole and heme biosynthesis in the yeast Sacchromyces cerevisiae. In: Dailey HA, ed. Biosynthesis of heme and cholorophylls. New York: Green Pub. Associates and Wiley-Interscience, 1990:235-285.
4. Wijayanti N, Katz N, Immenschuh S. Biology of heme in health and disease. Curr Med Chem 2004; 11:981-986.
5. Mattoon J, Lancashire W, Sanders H, et al. Oxygen and catabolite regulation of hemoprotein biosynthesis in the yeast Saccharomyces cerevisiae. In: Caughey WJ, ed. Biosynthesis of heme and cholorophylls. New York: Academic Press, 1979:421-435.
6. Poyton RO. Models for oxygen sensing in yeast: implications for oxygen-regulated gene expression in higher eucaryotes. Respir Physiol 1999; 115:119-133.
7. Atamna H, Walter PB, Ames BN. The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch Biochem Biophys 2002; 397:345-353.
8. Hon T, Dodd A, Dirmeier R, et al. A mechanism of oxygen sensing in yeast: multiple oxygen-responsive steps in the heme biosynthetic pathway affect Hap1 activity. J Biol Chem 2003; 278:50771-50780.
9. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997; 89:1-25.
10. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radical Biol Med 2000; 28:289-309.
11. Padmanaban G, Venkateswar V, Rangarajan PN. Haem as a multifunctional regulator. Trends Biochem Sci 1989; 14:492-496.
12. Sassa S, Nagai T. The role of heme in gene expression. Int J Hematol 1996; 63:167-178.
13. Ponka P. Cell biology of heme. Am J Med Sci 1999; 318:241-256.
14. Zhang L, Hach A. Molecular mechanism of heme signaling in yeast: the transcriptional activator Hap1 serves as the key mediator. Cell Mol Life Sci 1999; 56:415-426.
15. Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 2005; 157:175-188.
16. Rodgers KR. Heme-based sensors in biological systems. Curr Opin Chem Biol 1999; 3:158-167.
17. Zhu Y, Hon T, Ye W, Zhang L. Heme deficiency interferes with the Ras-mitogen-activated protein kinase signaling pathway and expression of a subset of neuronal genes. Cell Growth Differ 2002; 13:431-439.
18. Zhu Y, Hon T, Zhang L. Heme initiates changes in the expression of a wide array of genes during the early erythroid differentiation stage. Biochem Biophys Res Commun 1999; 258:87-93.
19. Zhu Y, Lee HC, Zhang L. An examination of heme action in gene expression: heme and heme deficiency affect the expression of diverse genes in erythroid k562 and neuronal PC12 cells. DNA Cell Biol 2002; 21:333-346.
20. Sengupta A, Hon T, Zhang L. Heme deficiency suppresses the expression of key neuronal genes and causes neuronal cell death. Brain Res Mol Brain Res 2005; 137:23-30.
21. Qi Z, Hamza I, O'Brian MR. Heme is an effector molecule for iron-dependent degradation of the bacterial iron response regulator (Irr) protein. Proc Natl Acad Sci USA 1999; 96:13056-13061.
22. Ogawa K, Sun J, Taketani S, et al. Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J 2001; 20:2835-2843.
23. Chen JJ, London IM. Regulation of protein synthesis by heme-regulated eIF-2 alpha kinase. Trends Biochem Sci 1995; 20:105-108.
24. Kwast KE, Burke PV, Poyton RO. Oxygen sensing and the transcriptional regulation of oxygen-responsive genes in yeast. J Exp Biol 1998; 201:1177-1195.
25. Zitomer RS, Lowry CV. Regulation of gene expression by oxygen in Saccharomyces cerevisiae. Microbiol Rev 1992; 56:1-11.
26. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996; 76:839-885.
27. Zitomer RS, Carrico P, Deckert J. Regulation of hypoxic gene expression in yeast. Kidney Int 1997; 51:507-513.
28. Zhang L, Hach A, Wang C. Molecular mechanism governing heme signaling in yeast: a higher-order complex mediates heme regulation of the transcriptional activator HAP1. Mol Cell Biol 1998; 18:3819-3828.
29. Zhang L, Guarente L. Heme binds to a short sequence that serves a regulatory function in diverse proteins. EMBO J 1995; 14:313-320.
30. Hon T, Hach A, Tamalis D, et al. The yeast heme-responsive transcriptional activator Hap1 is a preexisting dimer in the absence of heme. J Biol Chem 1999; 274:22770-22774.
31. Hon T, Lee HC, Hach A, et al. The Hsp70-Ydj1lmolecular chaperone represses the activity of the heme activator protein Hap1 in the absence of heme. Mol Cell Biol 2001; 21:7923-7932.
32. King DA, Zhang L, Guarente L, Marmorstein R. Structure of a HAP1/DNA complex reveals dramatically asymmetric DNA binding by a homodimeric protein. Nat Struct Biol 1999; 6:64-71.
33. Zhang L, Guarente L. The C6 zinc cluster dictates asymmetric binding by HAP1. EMBO J 1996; 15:4676-4681.
34. Lee HC, Hon T, Lan C, Zhang L. Structural environment dictates the biological significance of heme-responsive motifs and the role of Hsp90 in the activation of the heme activator protein Hap1. Mol Cell Biol 2003; 23:5857-5866.
35. Pfeifer K, Kim KS, Kogan S, Guarente L. Functional dissection and sequence of yeast HAP1 activator. Cell 1989; 56:291-301.
36. Lan C, Lee HC, Tang S, Zhang L. A novel mode of chaperone action: heme activation of hap1 by enhanced association of Hsp90 with the repressed Hsp70-Hap1 complex. J Biol Chem 2004; 279:27607-27612.
37. Lee HC, Hon T, Zhang L. The molecular chaperone Hsp90 mediates heme activation of the yeast transcriptional activator Hap1. J Biol Chem 2002; 277:7430-7437.
38. Lathrop JT, Timko MP. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science 1993; 259:522-525.
39. Steiner H, Kispal G, Zollner A, et al. Heme binding to a conserved Cys-Pro-Val motif is crucial for the catalytic function of mitochondrial heme lyases. J Biol Chem 1996; 271:32605-32611.
40. Hach A, Hon T, Zhang L. A new class of repression modules is critical for heme regulation of the yeast transcriptional activator Hap1. Mol Cell Biol 1999; 19:4324-4333.
41. Hon T, Hach A, Lee HC, et al. Functional analysis of heme regulatory elements of the transcriptional activator Hap1. Biochem Biophys Res Commun 2000; 273:584-591.
42. Yang J, Ishimori K, O'Brian MR. Two heme binding sites are involved in the regulated degradation of the bacterial iron response regulator (Irr) protein. J Biol Chem 2005; 280:7671-7676.
43. Gao T, O'Brian MR. Iron-dependent cytochrome c1 expression is mediated by the status of heme in Bradyrhizobium japonicum. J Bacteriol 2005; 187:5084-5089.
44. Hamza I, Chauhan S, Hassett R, O'Brian MR. The bacterial irr protein is required for coordination of heme biosynthesis with iron availability. J Biol Chem 1998; 273:21669-21674.
45. Qi Z, O'Brian MR. Interaction between the bacterial iron response regulator and ferrochelatase mediates genetic control of heme biosynthesis. Mol Cell 2002; 9:155-162.
46. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996; 93:8175-8182.
47. Rouault TA, Klausner RD. Iron-sulfur clusters as biosensors of oxidants and iron. Trends Biochem Sci 1996; 21:174-177.
48. Chauhan S, Titus DE, O'Brian MR. Metals control activity and expression of the heme biosynthesis enzyme delta-aminolevulinic acid dehydratase in Bradyrhizobium japonicum. J Bacteriol 1997; 179:5516-5520.
49. Yang J, Sangwan I, Lindemann A, et al. Bradyrhizobium japonicum senses iron through the status of haem to regulate iron homeostasis and metabolism. Mol Microbiol 2006; 60:427-437.
50. Yang J, Panek HR, O'Brian MR. Oxidative stress promotes degradation of the Irr protein to regulate haem biosynthesis in Bradyrhizobium japonicum. Mol Microbiol 2006; 60:209-218.
51. Koury MJ, Koury ST, Kopsombut P, Bondurant MC. In vitro maturation of nascent reticulocytes to erythrocytes. Blood 2005; 105:2168-2174.
52. Han AP, Fleming MD, Chen JJ. Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. J Clin Invest 2005; 115:1562-1570.
53. Ponka P, Sheftel AD, Zhang AS. Iron targeting to mitochondria in erythroid cells. Biochem Soc Trans 2002; 30:735-738.
54. Yun BG, Matts JA, Matts RL. Interdomain interactions regulate the activation of the heme-regulated eIF 2 alpha kinase. Biochim Biophys Acta 2005; 1725:174-181.
55. Wek RC. eIF-2 kinases: regulators of general and gene-specific translation initiation. Trends Biochem Sci 1994; 19:491-496.
56. Chen JJ, Throop MS, Gehrke L, et al. Cloning of the cDNA of the heme-regulated eukaryotic initiation factor 2 alpha (eIF-2 alpha) kinase of rabbit reticulocytes: homology to yeast GCN2 protein kinase and human double-stranded-RNA-dependent eIF-2 alpha kinase. Proc Natl Acad Sci USA 1991; 88:7729-7733.
57. de Haro C, Mendez R, Santoyo J. The eIF-2alpha kinases and the control of protein synthesis. FASEB J 1996; 10:1378-1387.
58. Colthurst DR, Campbell DG, Proud CG. Structure and regulation of eukaryotic initiation factor eIF-2. Sequence of the site in the alpha subunit phosphorylated by the haem-controlled repressor and by the double-stranded RNA-activated inhibitor. Eur J Biochem 1987; 166:357-363.
59. Uma S, Matts RL, Guo Y, et al. The N-terminal region of the heme-regulated eIF2alpha kinase is an autonomous heme binding domain. Eur J Biochem 2000; 267:498-506.
60. Bauer BN, Rafie-Kolpin M, Lu L, et al. Multiple autophosphorylation is essential for the formation of the active and stable homodimer of heme-regulated eIF2alpha kinase. Biochemistry 2001; 40:11543-11551.
61. Rafie-Kolpin M, Chefalo PJ, Hussain Z, et al. Two heme-binding domains of heme-regulated eukaryotic initiation factor-2alpha kinase. N terminus and kinase insertion. J Biol Chem 2000; 275:5171-5178.
62. Chefalo PJ, Oh J, Rafie-Kolpin M, et al. Heme-regulated eIF-2alpha kinase purifies as a hemoprotein. Eur J Biochem 1998; 258:820-830.
63. Uma S, Yun BG, Matts RL. The heme-regulated eukaryotic initiation factor 2alpha kinase. A potential regulatory target for control of protein synthesis by diffusible gases. J Biol Chem 2001; 276:14875-14883.
64. Matts RL, Hurst R. Evidence for the association of the heme-regulated eIF-2 alpha kinase with the 90-kDa heat shock protein in rabbit reticulocyte lysate in situ. J Biol Chem 1989; 264:15542-15547.
65. Xu Z, Pal JK, Thulasiraman V, et al. The role of the 90-kDa heat-shock protein and its associated cohorts in stabilizing the heme-regulated eIF-2alpha kinase in reticulocyte lysates during heat stress. Eur J Biochem 1997; 246:461-470.
66. Matts RL, Hurst R. The relationship between protein synthesis and heat shock proteins levels in rabbit reticulocyte lysates. J Biol Chem 1992; 267:18168-18174.
67. Shao J, Grammatikakis N, Scroggins BT, et al. Hsp90 regulates p50(cdc37) function during the biogenesis of the active conformation of the heme-regulated eIF2 alpha kinase. J Biol Chem 2001; 276:206-214.
68. Thulasiraman V, Yun BG, Uma S, et al. Differential inhibition of Hsc70 activities by two Hsc70-binding peptides. Biochemistry 2002; 41:3742-3753.
69. Uma S, Hartson SD, Chen JJ, Matts RL. Hsp90 is obligatory for the heme-regulated eIF-2alpha kinase to acquire and maintain an activable conformation. J Biol Chem 1997; 272:11648-11656.
70. Shao J, Hartson SD, Matts RL. Evidence that protein phosphatase 5 functions to negatively modulate the maturation of the Hsp90-dependent heme-regulated eIF2alpha kinase. Biochemistry 2002; 41:6770-6779.
71. Uma S, Thulasiraman V, Matts RL. Dual role for Hsc70 in the biogenesis and regulation of the heme-regulated kinase of the alpha subunit of eukaryotic translation initiation factor 2. Mol Cell Biol 1999; 19:5861-5871.
72. Kitamuro T, Takahashi K, Ogawa K, et al. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 2003; 278:9125-9133.
73. Ishikawa M, Numazawa S, Yoshida T. Redox regulation of the transcriptional repressor Bach1. Free Radical Biol Med 2005; 38:1344-1352.
74. Igarashi K, Itoh K, Hayashi N, et al. Conditional expression of the ubiquitous transcription factor MafK induces erythroleukemia cell differentiation. Proc Natl Acad Sci USA 1995; 92:7445-7449.
75. Igarashi K, Itoh K, Motohashi H, et al. Activity and expression of murine small Maf family protein MafK. J Biol Chem 1995; 270:7615-7624.
76. Igarashi K, Kataoka K, Itoh K, et al. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 1994; 367:568-572.
77. Yamasaki C, Tashiro S, Nishito Y, et al. Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP. J Biochem (Tokyo) 2005; 137:287-296.
78. Ishii T, Itoh K, Takahashi S, et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000; 275:16023-16029.
79. Hoshino H, Igarashi K. Expression of the oxidative stress-regulated transcription factor bach2 in differentiating neuronal cells. J Biochem (Tokyo) 2002; 132:427-431.
80. Sun J, Hoshino H, Takaku K, et al. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 2002; 21:5216-5224.
81. Sun J, Muto A, Hoshino H, et al. The promoter of mouse transcription repressor bach1 is regulated by Sp1 and trans-activated by Bach1. J Biochem (Tokyo) 2001; 130:385-392.
82. Oyake T, Itoh K, Motohashi H, et al. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 1996; 16:6083-6095.
83. Suzuki H, Tashiro S, Hira S, et al. Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1. EMBO J 2004; 23:2544-2553.
84. Suzuki H, Tashiro S, Sun J, et al. Cadmium induces nuclear export of Bach1, a transcriptional repressor of heme oxygenase-1 gene. J Biol Chem 2003; 278:49246-49253.
85. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73:2424-2428.
86. De Matteis F, Marks GS. The effect of N-methylprotoporphyrin and succinyl-acetone on the regulation of heme biosynthesis in chicken hepatocytes in culture. FEBS Lett 1983; 159:127-131.
87. Gage FH, Buzsaki G, Armstrong DM. NGF-dependent sprouting and regeneration in the hippocampus. Prog Brain Res 1990; 83:357-370.
88. Alleva E, Petruzzi S, Cirulli F, Aloe L. NGF regulatory role in stress and coping of rodents and humans. Pharmacol Biochem Behav 1996; 54:65-72.
89. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999; 68:821-861.
90. Ye W, Zhang L. Heme controls the expression of cell cycle regulators and cell growth in HeLa cells. Biochem Biophys Res Commun 2004; 315:546-554.
91. Ye W, Zhang L. Heme deficiency causes apoptosis but does not increase ROS generation in HeLa cells. Biochem Biophys Res Commun 2004; 319:1065-1071.
92. Scarlett YV, Brenner DA. Porphyrias. J Clin Gastroenterol 1998; 27:192-198.
93. Scarlett YV, Brenner DA, Bloomer JR. Hepatic porphyrias. Clin Liver Dis 1998; 2:77-102, vi.
94. Grandchamp B. Acute intermittent porphyria. Semin Liver Dis 1998; 18:17-24.
95. Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 1998; 18:43-52.
96. Moore MR. Historical introduction to porphyrins and porphyrias. In: Dailey HA, ed. Biosynthesis of heme and cholorophylls. New York: Green Pub. Associates and Wiley-Interscience, 1990:1-54.
97. Tenhunen R, Mustajoki P. Acute porphyria: treatment with heme. Semin Liver Dis 1998; 18:53-55.
98. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudt AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: The McGraw-Hill Companies Inc., 1995:2103-2160.
99. Desnick RJ, Glass IA, Xu W, et al. Molecular genetics of congenital erythropoietic porphyria. Semin Liver Dis 1998; 18:77-84.
100. Nordmann Y, Deybach J-C. Human hereditary porphyrias. In: Dailey HA, ed. Biosynthesis of heme and cholorophylls. New York: Green Pub. Associates and Wiley-Interscience, 1990:491-541.
101. Bressler JP, Goldstein GW. Mechanisms of lead neurotoxicity. Biochem Pharmacol 1991; 41:479-484.
102. Atamna H. Heme, iron, and the mitochondrial decay of ageing. Ageing Res Rev 2004; 3:303-318.
103. Schipper HM. Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 2000; 35:821-830.
104. Schipper HM, Chertkow H, Mehindate K, et al. Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 2000; 54:1297-1304.
105. Schipper HM, Cisse S, Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 1995; 37:758-768.
106. Smith MA, Nunomura A, Zhu X, et al. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal 2000; 2:413-420.
107. Kimpara T, Takeda A, Yamaguchi T, et al. Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease. Neurobiol Aging 2000; 21:551-54.
108. Atamna H, Liu J, Ames BN. Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: relevance to aging. J Biol Chem 2001; 276:48410-48416.
109. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Biol Med 2000; 29:222-230.
110. Han D, Williams E, Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J 2001; 353:411-416.
111. Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000; 25:502-508.
112. Albers DS, Beal MF. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl 2000; 59:133-154.
113. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78:547-581.
114. Parker WD Jr, Parks J, Filley CM, Kleinschmidt-DeMasters BK. Electron transport chain defects in Alzheimer's disease brain. Neurology 1994; 44:1090-1096.
115. Maurer I, Zierz S, Moller H. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 2001; 48:125-136.
116. Wielburski A, Nelson BD. Heme a induces assembly of rat liver cytochrome c oxidase subunits I-III in isolated mitochondria. FEBS Lett 1984; 177:291-294.
117. Ames BN, Atamna H, Killilea DW. Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging. Mol Aspects Med 2005; 26:363-378.
118. Ames BN. Delaying the mitochondrial decay of aging. Ann NY Acad Sci 2004; 1019:406-411.
119. Balla J, Balla G, Jeney V, et al. Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants. Blood 2000; 95:3442-3450.
120. Jeney V, Balla J, Yachie A, et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002; 100:879-887.
121. Chou AC, Fitch CD. Mechanism of hemolysis induced by ferriprotoporphyrin IX. J Clin Invest 1981; 68:672-677.
122. Liu SC, Zhai S, Lawler J, Palek J. Hemin-mediated dissociation of erythrocyte membrane skeletal proteins. J Biol Chem 1985; 260:12234-12239.
123. Wagener FA, Volk HD, Willis D, et al. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003; 55:551-571.
124. Gutteridge JM, Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 1988; 256:861-865.
125. Lavrovsky Y, Song CS, Chatterjee B, Roy AK. Age-dependent increase of heme oxygenase-1 gene expression in the liver mediated by NFkappaB. Mech Ageing Dev 2000; 114:49-60.
126. Letarte PB, Lieberman K, Nagatani K, et al. Hemin: levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth-muscle cells. J Neurosurg 1993; 79:252-255.
127. Wagener, Feldman E, de Witte T, Abraham NG. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med 1997; 216:456-463.
128. Balla G, Vercellotti GM, Muller-Eberhard U, et al. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 1991; 64:648-655.
129. Balla G, Jacob HS, Eaton JW, et al. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 1991; 11:1700-1711.
130. Schmitt TH, Frezzatti WA Jr, Schreier S. Hemin-induced lipid membrane disorder and increased permeability: a molecular model for the mechanism of cell lysis. Arch Biochem Biophys 1993; 307:96-103.
131. Vincent SH. Oxidative effects of heme and porphyrins on proteins and lipids. Semin Hematol 1989; 26:105-113.
132. Aft RL, Mueller GC. Hemin-mediated oxidative degradation of proteins. J Biol Chem 1984; 259:301-305.
133. Camejo G, Halberg C, Manschik-Lundin A, et al. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 1998; 39:755-766.
134. Aft RL, Mueller GC. Hemin-mediated DNA strand scission. J Biol Chem 1983; 258:12069-12072.
135. Van Langendonckt A, Casanas-Roux F, Dolmans MM, Donnez J. Potential involvement of hemoglobin and heme in the pathogenesis of peritoneal endometriosis. Fertil Steril 2002; 77:561-570.
136. Nath KA, Vercellotti GM, Grande JP, et al. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int 2001; 59:106-117.
137. Nath KA, Balla J, Croatt AJ, Vercellotti GM. Heme protein-mediated renal injury: a protective role for 21-aminosteroids in vitro and in vivo. Kidney Int 1995; 47:592-602.
138. Lavrovsky Y, Schwartzman ML, Levere RD, et al. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 1994; 91:5987-5991.
139. Shono T, Ono M, Izumi H, et al. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 1996; 16:4231-4239.
140. Wagener FA, Eggert A, Boerman OC, et al. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 2001; 98:1802-1811.
141. Wagner KR, Sharp FR, Ardizzone TD, et al. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 2003; 23:629-652.
142. Tolosano E, Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol 2002; 21:297-306.
143. Delanghe JR, Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 2001; 312:13-23.
144. Smith A, Hunt RC. Hemopexin joins transferrin as representative members of a distinct class of receptor-mediated endocytic transport systems. Eur J Cell Biol 1990; 53:234-245.
145. Alam J, Smith A. Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells. J Biol Chem 1989; 264:17637-17640.
146. Smith A, Morgan WT. Hemopexin-mediated transport of heme into isolated rat hepatocytes. J Biol Chem 1981; 256:10902-10909.
147. Grinberg LN, O'Brien PJ, Hrkal Z. The effects of heme-binding proteins on the peroxidative and catalatic activities of hemin. Free Radical Biol Med 1999; 27:214-219.
148. Iwahara S, Satoh H, Song DX, et al. Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry 1995; 34:13398-13406.
149. Immenschuh S, Iwahara S, Satoh H, et al. Expression of the mRNA of heme-binding protein 23 is coordinated with that of heme oxygenase-1 by heme and heavy metals in primary rat hepatocytes and hepatoma cells. Biochemistry 1995; 34:13407-13411.
150. Taketani S, Adachi Y, Kohno H, et al. Molecular characterization of a newly identified heme-binding protein induced during differentiation of urine erythroleukemia cells. J Biol Chem 1998; 273:31388-31394.
151. McCoubrey WK, Jr., Huang TJ, Maines MD. Heme oxygenase-2 is a hemoprotein and binds heme through heme regulatory motifs that are not involved in heme catalysis. J Biol Chem 1997; 272:12568-12574.
152. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 1986; 261:411-419.
153. Hayashi S, Omata Y, Sakamoto H, et al. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 2004; 336:241-250.
154. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969; 244:6388-6394.
155. Noguchi M, Yoshida T, Kikuchi G. Identification of the product of heme degradation catalyzed by the heme oxygenase system as biliverdin IX alpha by reversed-phase high-performance liquid chromatography. J Biochem (Tokyo) 1982; 91:1479-1483.
156. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988; 2:2557-2568.
157. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043-1046.
158. Baranano DE, Snyder SH. Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci USA 2001; 98:10996-11002.
159. Nakagami T, Toyomura K, Kinoshita T, Morisawa S. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1993; 1158:189-193.
160. Dore S, Takahashi M, Ferris CD, et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 1999; 96:2445-2450.
161. Llesuy SF, Tomaro ML. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta 1994; 1223:9-14.
162. Sikorski EM, Hock T, Hill-Kapturczak N, Agarwal A. The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 2004; 286:F425-F441.
163. Schipper HM. Heme oxygenase expression in human central nervous system disorders. Free Radical Biol Med 2004; 37:1995-2011.
164. Immenschuh S, Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 2000; 60:1121-1128.
165. Kacimi R, Chentoufi J, Honbo N, et al. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc Res 2000; 46:139-150.
166. Lee PJ, Jiang BH, Chin BY, et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997; 272:5375-5381.
167. Motterlini R, Foresti R, Bassi R, et al. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 2000; 275:13613-13620.
168. Shibahara S, Nakayama M, Kitamuro T, et al. Repression of heme oxygenase-1 expression as a defense strategy in humans. Exp Biol Med (Maywood) 2003; 228:472-473.
169. Takahashi S, Takahashi Y, Yoshimi T, Miura T. Oxygen tension regulates heme oxygenase-1 gene expression in mammalian cell lines. Cell Biochem Funct 1998; 16:183-193.
170. Yang ZZ, Zou AP. Transcriptional regulation of heme oxygenases by HIF-1alpha in renal medullary interstitial cells. Am J Physiol Renal Physiol 2001; 281:F900-F908.